377 related articles for article (PubMed ID: 26119687)
1. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders.
Sempoux C; Paradis V; Komuta M; Wee A; Calderaro J; Balabaud C; Quaglia A; Bioulac-Sage P
J Hepatol; 2015 Nov; 63(5):1173-80. PubMed ID: 26119687
[TBL] [Abstract][Full Text] [Related]
2. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
5. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
[TBL] [Abstract][Full Text] [Related]
8. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
Cho SJ; Ferrell LD; Gill RM
Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
[TBL] [Abstract][Full Text] [Related]
9. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
Saldarriaga J; Bisig B; Couchy G; Castain C; Zucman-Rossi J; Balabaud C; Sempoux C; Bioulac-Sage P
Histopathology; 2017 Dec; 71(6):989-993. PubMed ID: 28618047
[TBL] [Abstract][Full Text] [Related]
10. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.
Larson BK; Guindi M
Am J Clin Pathol; 2017 Jun; 147(6):557-570. PubMed ID: 28472207
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Adenoma in an Infant With Burn-McKeown Syndrome: Report of a Case.
González IA; Surrey LF; Russo P
Pediatr Dev Pathol; 2022; 25(6):668-671. PubMed ID: 36262073
[TBL] [Abstract][Full Text] [Related]
12. Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar.
Maetani Y; Itoh K; Egawa H; Haga H; Sakurai T; Nishida N; Ametani F; Shibata T; Kubo T; Tanaka K; Konishi J
AJR Am J Roentgenol; 2002 Apr; 178(4):869-75. PubMed ID: 11906865
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous Occurrence of Various Types of Hepatocellular Adenoma in the Livers of Metabolic Syndrome-Associated Steatohepatitis Model TSOD Mice.
Shao W; Jargalsaikhan O; Ichimura-Shimizu M; Cai Q; Ogawa H; Miyakami Y; Atsumi K; Tomita M; Sutoh M; Toyohara S; Hokao R; Kudo Y; Oya T; Tsuneyama K
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233225
[TBL] [Abstract][Full Text] [Related]
14. Focal hyperplastic hepatocellular nodules in hepatic venous outflow obstruction: a clinicopathological study of four patients and 24 nodules.
Ibarrola C; Castellano VM; Colina F
Histopathology; 2004 Feb; 44(2):172-9. PubMed ID: 14764061
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature.
Hechtman JF; Raoufi M; Fiel MI; Taouli B; Facciuto M; Schiano TD; Blouin AG; Thung SN
Am J Surg Pathol; 2011 Jun; 35(6):927-32. PubMed ID: 21572265
[TBL] [Abstract][Full Text] [Related]
16. Budd-Chiari syndrome with multiple large regenerative nodules.
Kim H; Nahm JH; Park YN
Clin Mol Hepatol; 2015 Mar; 21(1):89-94. PubMed ID: 25834807
[No Abstract] [Full Text] [Related]
17. Malignant transformation of hepatic adenomas.
Micchelli ST; Vivekanandan P; Boitnott JK; Pawlik TM; Choti MA; Torbenson M
Mod Pathol; 2008 Apr; 21(4):491-7. PubMed ID: 18246041
[TBL] [Abstract][Full Text] [Related]
18. Multiple hyperplastic nodular lesions of the liver in the Budd-Chari syndrome: a case report and review of published reports.
Wang Y; Xue H; Jiang Q; Li K; Tian Y
Ann Saudi Med; 2015; 35(1):72-5. PubMed ID: 26142943
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
[TBL] [Abstract][Full Text] [Related]
20. Comparison of imaging characteristics between hepatic benign regenerative nodules and hepatocellular carcinomas associated with Budd-Chiari syndrome by contrast enhanced ultrasound.
Zhang R; Qin S; Zhou Y; Song Y; Sun L
Eur J Radiol; 2012 Nov; 81(11):2984-9. PubMed ID: 22341409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]